BerganT., DalhoffA., RahwedderR.. Pharmacokinetics of ciprofloxacin. Infection1988; 16(suppl 1): S3–13.
2.
DillardM.L., FinkR.M., ParkersonR.. Ciprofloxacin–phenytoin interaction (letter). Ann Pharmacother1992; 26: 263.
3.
AnastasioG.D., MenscerD., LittleJ.M.. Norfloxacin and seizures (letter). Ann Intern Med1988; 109: 169–70.
4.
HoignéR., MalinverniR., SonntagR.. Sulfonamides, other folic acid antagonists and miscellaneous antibacterial agents. In: DukesM.N.G., ed. Meyler's side effects of drugs.12th ed.Amsterdam: Elsevier Science Publishers, BV, 1992: 715–41.
5.
JobM.L., ArnS.K., StromJ.G., JacobsN.F., D'SouzaM.J.. Effect of ciprofloxacin on the pharmacokinetics of multiple-dose phenytoin serum concentrations. Ther Drug Monit1994; 16: 427–31.
6.
GlazkoA.J.. Diphenylhydantoin metabolism. A prospective review. Drug Metab Dispos1973; 5: 711–4.
7.
PeruccaE.. Free level monitoring of antiepileptic drugs; clinical usefulness and case studies. Clin Pharmacokinet1984; 9(suppl 1): 71–8.